SCHEMBL1669826

SCHEMBL1669826

N=NOCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15358714 0.71
SCHEMBL15109119 0.71
SCHEMBL15499989 0.71
SCHEMBL8957114 0.67
SCHEMBL17770697 0.65
SCHEMBL1038811 0.65
SCHEMBL1561675 0.65
SCHEMBL612525 0.63 TSHR (0.38)
SCHEMBL15112 0.63
Hydrochloric Acid SCHEMBL3889714 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10835578-B2 CNP prodrugs with large carrier moieties ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) 2020-11-17 US disclosed
US-20190328840-A1 CONTROLLED-RELEASE CNP AGONISTS WITH LOW INITIAL NPR-B ACTIVITY ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) 2019-10-31 US disclosed
US-20190015481-A1 CNP PRODRUGS WITH LARGE CARRIER MOIETIES ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) 2019-01-17 US disclosed
US-20190008977-A1 CNP PRODRUGS WITH CARRIER ATTACHMENT AT THE RING MOIETY ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) 2019-01-10 US disclosed
EP-2741778-A1 POLYMERIC HYPERBRANCHED CARRIER-LINKED PRODRUGS Ascendis Pharma A/S (DK) 2014-06-18 EP disclosed
WO-2013024048-A1 POLYMERIC HYPERBRANCHED CARRIER-LINKED PRODRUGS ASCENDIS PHARMA A/S (DK) 2013-02-21 WO disclosed
EP-2485767-A1 CARRIER LINKED PALIPERIDONE PRODRUGS Ascendis Pharma A/S (DK) 2012-08-15 EP disclosed
WO-2011042450-A1 CARRIER LINKED PALIPERIDONE PRODRUGS ASCENDIS PHARMA AS (DK) 2011-04-14 WO disclosed